BackgroundCheck.run
Search For

Henry Hongjun Ji, 60Rancho Santa Fe, CA

Known as:
Henry H Ji Hongjun Ji Hong Jun Ji Hong-Jun Ji Hongjung Ji Henry Je Jun Ji Hong Ji Hong Ji Hong-Jun
Related to:
Peter Xia 68

Henry Ji Phones & Addresses

Rancho Santa Fe, CA   

Solana Beach, CA   

5370 Ruette De Mer, San Diego, CA 92130    858-7209680   

Saint Paul, MN   

Germantown, MD   

Get Report
Control this profile

Mentions for Henry Hongjun Ji

Resumes & CV records

Resumes

Henry Ji Photo 33

Vice President And Co-Founder And Lead Artist

Location:
7900 Quimby Ave, West Hills, CA 91304
Industry:
Computer Games
Work:
Game Mechanic Studios
Vice President and Co-Founder and Lead Artist Electronic Arts (Ea) 2008 - 2008
Senior Environment Artist Neversoft Entertainment 2001 - 2007
Senior Artist Black Ops Feb 2000 - Oct 2001
Environment Artist Novalogic Jan 2001 - Apr 2001
Environment Artist
Education:
Savannah College of Art and Design 1995 - 1998
Bachelors, Fine Art
Skills:
Texturing, Video Games, Game Development, Game Design, 3D Modeling, Environment Art, Maya, Photoshop, 3D Studio Max, Unreal Engine 3, Ps3, Zbrush, Game Mechanics, Art, Character Animation, Entrepreneurship
Henry Ji Photo 34

Playtest Operations Associate

Location:
Los Angeles, CA
Work:
Riot Games
Playtest Operations Associate
Education:
University of Southern California - Marshall School of Business 2014 - 2018
Bachelors, Bachelor of Science
Henry Ji Photo 35

Engineer

Industry:
Computer Software
Work:
Ji Corp
Engineer
Henry Ji Photo 36

Henry Ji

Henry Ji Photo 37

Henry Ji

Publications & IP owners

Us Patents

Polynucleotides Encoding A Protein Kinase C Inhibitor Protein And Methods Of Using These Polynucleotides

US Patent:
7335489, Feb 26, 2008
Filed:
Jun 4, 2003
Appl. No.:
10/453478
Inventors:
Paul A. Moore - North Bethesda MD, US
Reiner L. Gentz - Belo Horizonte-Mg, BR
Henry Hongjun Ji - San Diego CA, US
Jian Ni - Germantown MD, US
Jing-Shan Hu - Mountain View CA, US
Craig A. Rosen - Laytonsville MD, US
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
C07K 14/35
C12N 15/00
C12N 5/00
C12N 1/20
C07H 21/04
C07H 21/02
C07K 14/435
US Classification:
435 691, 4353201, 435325, 4352523, 536 235, 536 231, 530350
Abstract:
Human polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for therapeutic purposes. Antagonists against such polypeptides and their use as a therapeutic are also disclosed. Also disclosed are diagnostic methods for detecting disease which utilize the sequences and polypeptides.

Method For Cloning Variable Domain Sequences Of Immunological Gene Repertoire

US Patent:
7405062, Jul 29, 2008
Filed:
May 14, 2002
Appl. No.:
10/477907
Inventors:
Henry Ji - San Diego CA, US
Assignee:
San Diego Antibody - San Diego CA
International Classification:
C12P 19/34
C12Q 1/68
US Classification:
435 912, 435 6
Abstract:
The present invention relates to a non-PCR (polymerase chain reaction) process, particularly a transcription-based amplification method, for amplifying and cloning sequences containing a variable domain sequence such as an immunoglobulin variable domain sequence from the immunological gene repertoire. The present invention comtemplates the expression of antibody library in either in an in vivo expression vector or in an in vitro transcription/translation system. Isolation of a gene coding for a receptor having the ability to bind a preselected ligand and receptors produced by the gene isolated by the method is also contemplated.

Method For Ligating Nucleic Acids And Molecular Cloning

US Patent:
2002018, Dec 5, 2002
Filed:
Jan 25, 2002
Appl. No.:
10/057050
Inventors:
Henry Ji - San Diego CA, US
Alan Greener - San Diego CA, US
Joseph Sorge - Wilson WY, US
John Bauer - San Diego CA, US
Richard Gibbs - Houston TX, US
Carsten-Peter Carstens - La Jolla CA, US
International Classification:
C12P019/34
C12N015/85
US Classification:
435/455000, 435/320100
Abstract:
The invention provides methods of covalently joining nucleic acid molecules and methods of molecular cloning. The methods provide either sequential or simultaneous ligation of flanking or vector nucleic acid molecules to nucleic acid insert molecules by topoisomerase and DNA ligase. The methods provide for directional and non-directional covalent joining and cloning of nucleic acid molecules.

Gene Targeting Methods And Vectors

US Patent:
2003002, Jan 30, 2003
Filed:
Jun 26, 2002
Appl. No.:
10/185980
Inventors:
Robert Marshall Burgess - San Diego CA, US
Henry Ji - San Diego CA, US
International Classification:
C12Q001/68
C12N015/00
US Classification:
435/006000, 435/320100, 800/013000
Abstract:
Methods and vectors are provided for the specific alteration of particular genetic loci in eukaryotic cells. One method includes the utilization of positive-positive selection (PPS) DNA vectors for the purpose of creating and identifying cells which have vector sequences integrated into the host cell genome via site-specific homologous recombination. The method also comprises the utilization of sequences encoding in vivo detectable markers for the identification of cells which have exogenous vector sequences integrated into the genome of the host cell, either via site-specific homologous recombination or nonhomologous recombination or insertion. The invention also includes vectors for creating modifications in eukaryotic cells.

Gene Targeting Methods And Vectors

US Patent:
2003013, Jul 17, 2003
Filed:
Dec 3, 2002
Appl. No.:
10/309757
Inventors:
Robert Burgess - Temecula CA, US
Henry Ji - San Diego CA, US
International Classification:
A01K067/00
A01H001/00
C12N015/82
C12N005/06
C12N005/04
C12N015/85
US Classification:
800/008000, 800/278000, 435/455000, 435/468000, 435/325000, 435/419000
Abstract:
Procedures and vectors are provided for the specific alteration of particular genetic loci in eukaryotic cells. One procedure utilizes fluorescence-probe-in-cell (FPIC) gene targeting DNA vectors for the purpose of creating and identifying cells which have vector sequences integrated into the host cell genome via site-specific homologous recombination. The procedure also utilizes sequences encoding in vivo detectable markers for the identification of cells which have exogenous vector sequences integrated into the genome of the host cell, either via site-specific homologous recombination or nonhomologous recombination or insertion. In addition, cells modified using a FPIC vector, and organisms generated from such cells, are provided.

Therapeutically Useful Compositions Of Dna-Rna Hybrid Duplex Constructs

US Patent:
2004008, May 6, 2004
Filed:
Mar 19, 2003
Appl. No.:
10/393450
Inventors:
Henry Ji - San Diego CA, US
International Classification:
A61K048/00
C12Q001/68
C12P019/34
US Classification:
514/044000, 435/006000, 435/091200
Abstract:
The present invention provides novel compositions and methods for suppressing the expression of a targeted gene using RNA-DNA hybrid constructs. The invention further provides novel methods and compositions for generating or producing RNA-DNA hybrids, whose quantity is high enough to be used for the invention's gene silencing transfection and possibly in therapeutics applications. This improved RNA-polymerase chain reaction method utilizes thermocycling steps of promoter-linked DNA or RNA template synthesis, in vitro transcription and then reverse transcription to bring up the amount of RNA-DNA hybrids up to two thousand folds within one round of the above procedure for specific gene silencing.

Gene Targeting Methods And Vectors

US Patent:
2004021, Oct 28, 2004
Filed:
May 19, 2004
Appl. No.:
10/850293
Inventors:
Robert Burgess - San Diego CA, US
Henry Ji - San Diego CA, US
Assignee:
GENOME BIOSCIENCES, LLC
International Classification:
C12Q001/68
C12N015/85
US Classification:
435/006000, 435/455000
Abstract:
Methods and vectors are provided for the specific alteration of particular genetic loci in eukaryotic cells. One method includes the utilization of positive-positive selection (PPS) DNA vectors for the purpose of creating and identifying cells which have vector sequences integrated into host cell genome via site-specific homologous recombination. The method also comprises the utilization of sequences encoding in vivo detectable markers for the identification of cells which have exogenous vector sequences integrated into the genome of the host cell, either via site-specific homologous recombination or nonhomologous recombination or insertion. The invention also includes vectors for creating modifications in eukaryotic cells.

Method For Ligating Nucleic Acids And Molecular Cloning

US Patent:
2007007, Mar 29, 2007
Filed:
Sep 18, 2006
Appl. No.:
11/523422
Inventors:
Henry Ji - San Diego CA, US
Alan Greener - San Diego CA, US
Joseph Sorge - Wilson WY, US
John Bauer - San Diego CA, US
Richard Gibbs - Houston TX, US
Carsten-Peter Carstens - La Jolla CA, US
International Classification:
C12N 15/09
C12P 19/34
US Classification:
435455000, 435091100
Abstract:
The invention provides methods of covalently joining nucleic acid molecules and methods of molecular cloning. The methods provide either sequential or simultaneous ligation of flanking or vector nucleic acid molecules to nucleic acid insert molecules by topoisomerase and DNA ligase. The methods provide for directional and non-directional covalent joining and cloning of nucleic acid molecules.

Possible Relatives

Daniel D Ji  Douglas K Ji  Eunjung Ji  Guo Ji  Hae K Ji  Hongbin Ji  Huafang M Ji  Henry Johnson  Henry A Stamschror  Henry A Stanaland 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.